http://www.biospace.comBioSpace RSS GeneratorWed, 19 Jun 2013 08:37:37 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.xconomy.com/san-diego/2011/05/19/autogenomics-withdraws-ipo/In a letter to federal regulators yesterday, Carlsbad, CA-based AutoGenomics withdrew its filing for an initial public offering, which the company submitted in July, 2008. The company said at that time that its IPO would be made only by means of a prospectus, with J.P. Morgan Securities Inc. acting as the sole book-running manager of the offering. CEO Fareed Kureshy gave no reason for withdrawing...Fri, 20 May 2011 12:00:00 AM GMThttp://www.xconomy.com/boston/2010/12/17/bg-medicine-yanks-ipo/Xconomy -- BG Medicine, a Waltham, MA-based developer of diagnostics technology, has withdrawn its second attempt at an initial public offering, after the deal failed to price, Dow Jones Newswires reports. Last week the firm set the targeted price range for its 4.75 million share IPO at $13 to $15 per share, giving it the potential to raise as much as $71.25 million. BG, which recently gained FDA clearance...Mon, 20 Dec 2010 12:00:00 AM GMThttp://www.pehub.com/30459/therox-cancels-ipo/PeHUB -- TherOx Inc., an Irvine, Calif.-based developer of devices for cardiac ischemia patients, has withdrawn registration for a $100 million IPO. It had planned to trade on the Nasdaq, with Citi and UBS serving as co-lead underwriters. The company has raised over $120 million in total VC funding since 1995, including a $30 million Series J round earlier this year. Wed, 04 Feb 2009 12:00:00 AM GMThttp://www.pehub.com/26797/biotrove-cancels-ipo/BioTrove Inc., a Woburn, Mass.-based maker of instruments and consumables for genomic analysis, high-throughput screening and molecular diagnostics, has withdrawn registration for a $75 million IPO, citing unfavorable market conditions. IThu, 18 Dec 2008 12:00:00 AM GMThttp://www.pehub.com/26770/another-vc-backed-ipo-bites-the-dust/Zonare Medical Systems Inc., a Mountain View, Calif.-based developer of ultrasound systems for diagnostic imaging, has withdrawn registration for an $86.25 million IPO. It had planned to trade on the Nasdaq under ticker symbol ZONE, with Citi and Piper Jaffray serving as co-lead underwriters.Thu, 18 Dec 2008 12:00:00 AM GMThttp://www.pehub.com/26423/transmedics-cancels-ipo/TransMedics Inc., an Andover, Mass.-based developer of portable life support systems for organ transplants, has withdrawn its registration for an $86.25 million IPO, citing market conditions. It haad planned to trade on the Nasdaq under ticker symbol TMDX, with Morgan Stanley serving as lead underwriter.Tue, 16 Dec 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN0547283220081205?rpc=44NEW YORK, Dec 5 (Reuters) - Acclarent Inc, a California maker of devices to treat sinusitis, withdrew its application on Friday for an initial public offering, citing "unfavorable market conditions," according to a regulatory filing.Mon, 08 Dec 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN0439111520081204?rpc=44NEW YORK, Dec 4 (Reuters) - Osmetech Plc, a U.K.-based maker of molecular diagnostic platforms, withdrew its application for an initial public offering in the United States, according to a regulatory filing on Tuesday.Fri, 05 Dec 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN1853313020080922?rpc=44NEW YORK, Sept 22 (Reuters) - Fluidigm Corp postponed its initial public offering on Monday, citing market conditions, according to one of the deal's underwriters.Tue, 23 Sep 2008 12:00:00 AM GMThttp://www.pehub.com/6120/xdx-cancels-ipo/XDx Inc., a South San Francisco-based molecular diagnostics company that develops tests for the monitoring of transplant rejection and autoimmune diseases, has withdrawn its registration for an $86.25 million IPO. No reason was given. The company had planned to trade on the Nasdaq, with JPMorgan and Morgan Stanley serving as co-lead underwriters.Mon, 08 Sep 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN2037735420080620?rpc=44WASHINGTON, June 20 (Reuters) - Medical technology company Broncus Technologies on Friday filed to withdraw its plans for an initial public offering, citing current market conditions.Mon, 23 Jun 2008 12:00:00 AM GMThttp://biz.yahoo.com/ap/080610/ccs_medical_ipo_withdrawal.html?.v=1NEW YORK (AP) -- Medical supply management company CCS Medical Holdings Inc. has canceled its proposed initial public offering of 10 million shares because difficult market conditions, according to a Securities and Exchange Commission filing on Monday.Tue, 10 Jun 2008 12:00:00 AM GMThttp://biz.yahoo.com/ap/080512/emphasys_medical_ipo_withdrawal.html?.v=1NEW YORK (AP) -- Emphasys Medical Inc., which developed a medical device to treat emphysema, has canceled its plans for an initial public offering, citing market conditions, according to a Securities and Exchange Commission filing Monday.Tue, 13 May 2008 12:00:00 AM GMT